INTRODUCTION
============

An increasing population age, defined as a rising median age in the population, has emerged as one of the most significant challenges and financial burdens for many countries. The Korean population is rapidly aging and becoming an aged society, as are other developed countries. As the population of Korea is rapidly aging due to low fertility and a long life span, the problem of the elderly is becoming a social issue. Approximately 14.3% of the Korean population was aged 65 or older in 2018, and the percentage is expected to rapidly rise to 20.3% in 2027 and 34.4% in 2050 \[[@b1-kjfm-19-0087]\]. Recent advances in science and medicine have led to research that elucidates aging mechanisms, and anti-aging medicine is emerging as a growing industry. The definition of anti-aging medicine is as follows: "measures taken to slow, stop, or even reverse phenomena related to aging, as well as to increase life span." \[[@b2-kjfm-19-0087]\] Anti-aging related health supplements, cosmetics, and hormone replacement therapy (HRT) have been developed and advertised in the media, but there is still a lack of scientific evidence. In this article, we will review the behavioral, dietary, and pharmacological approaches of anti-aging medicine.

CALORIE RESTRICTION AND MIMETICS
================================

Among all the anti-aging interventions, dietary interventions have shown the greatest potential. Calorie restriction, without malnourishing the individual, slows the aging process and expands the average and maximal lifespan in animals of diverse origin \[[@b3-kjfm-19-0087],[@b4-kjfm-19-0087]\]. McCay et al. \[[@b5-kjfm-19-0087]\] reported that restricting food intake in rats extended the median and maximum life span and decreased the onset and severity of chronic diseases. Subsequent findings emphasized that calorie restriction has effects on life-span in a wide range of organisms \[[@b4-kjfm-19-0087],[@b6-kjfm-19-0087],[@b7-kjfm-19-0087]\]. The positive effects of calorie restriction in humans has also been demonstrated in many studies. Calorie restriction while maintaining adequate nutrition has beneficial effects such as protecting against the development of obesity, cardiovascular disease, hypertension, and cancer \[[@b8-kjfm-19-0087]\]. In a controlled study, calorie restriction with high levels of physical activity showed a decrease in blood pressure, body weight, serum cholesterol levels, insulin levels, and other anthropometric and physiological parameters \[[@b9-kjfm-19-0087]\]. The mechanisms by which calorie restriction induces life-extending properties are not fully understood, but the following four potential target pathways have been suggested: the activation of AMP protein kinase (AMPK) \[[@b10-kjfm-19-0087]\] and sirtuins \[[@b11-kjfm-19-0087]\], inhibition of insulin-like growth factor-1 (IGF-1) signaling \[[@b12-kjfm-19-0087]\], and inhibition of mammalian target of rapamycin (mTOR) by rapamycin \[[@b13-kjfm-19-0087]\]. These pathways are the main hypothesized mechanisms of action of calorie restriction that control cell growth, mitochondrial function, and autophagy directly or indirectly \[[@b14-kjfm-19-0087]\]. However, despite the proven benefits of calorie restriction, it is a difficult technique to successfully use in humans as it is challenging to apply the treatment long-term, since it requires a high level of determination and self-control. This paradox led to the discovery of compounds that imitate the outcome of calorie restriction on health and lifespan without an actual restriction in calorie intake \[[@b15-kjfm-19-0087]\]. These compounds were named 'calorie restriction mimetics' (CRM). [Figure 1](#f1-kjfm-19-0087){ref-type="fig"} illustrates the schematic mechanisms in relation to CRM.

1. Activator of AMP Protein Kinase
----------------------------------

AMPK is activated when cellular energy levels are low, resulting in increased levels of AMP \[[@b16-kjfm-19-0087]\]. Activation of AMPK regulates whole-body metabolism. Activation of AMPK resulted in insulin-sensitizing effects along with the increased absorption of glucose in skeletal muscles, reduced hepatic glucose production, and increased fatty acid oxidation in several tissues \[[@b16-kjfm-19-0087]\]. Metformin, the first-line drug for type 2 diabetes mellitus (T2DM), inhibits gluconeogenesis with the activation of AMPK in the liver \[[@b17-kjfm-19-0087]\]. Numerous studies have demonstrated that metformin has positive effects on the anti-aging process among patients with T2DM \[[@b18-kjfm-19-0087]\]. In the UK Prospective Diabetes Study, metformin decreased the risk of cardiovascular disease \[[@b19-kjfm-19-0087]\], cancer incidence, and all-cause mortality \[[@b20-kjfm-19-0087]\]. when compared to other anti-diabetic drugs \[[@b21-kjfm-19-0087]\]. Furthermore, a large retrospective observational study that included over 180,000 individuals reported that patients with T2DM treated with metformin monotherapy lived longer than non-diabetic controls, but they did not investigate for a dose-response association \[[@b18-kjfm-19-0087]\].

2. Inhibitors of Growth Hormone/Insulin-Like Growth Factor-1 Axis
-----------------------------------------------------------------

Recent studies have shown that reduced somatotropic activity is related to an inhibited rate of aging, delayed onset of age-related diseases, and frailty associated with an extended lifespan \[[@b22-kjfm-19-0087]\]. IGF-1 is secreted by the liver in response to growth hormone (GH). Although a deficient level of IGF-1 is lethal, several studies have reported that a reduction in IGF-1 levels or IGF-1 action has positive effects on protecting against cancer, diabetes mellitus, and can extend the lifespan of animal models \[[@b23-kjfm-19-0087]\]. Similar results have been shown in GH receptor-deficient Laron syndrome patients. Cells/tissues that produce or respond to GH and/or IGF-1 can be pharmacological targets for lowering IGF-1 action. One of the somatostatin analogs decreases serum GH/IGF-1 levels by suppressing GH secretion by pituitary somatotrophs. Regrettably, these compounds also suppress insulin secretion and have significant adverse effects including diarrhea, anorexia, the formation of gallstones. Thus, the use of somatostatin analogs as an anti-aging treatment is currently unwarranted. Pegvisomant, another drug for treating acromegaly, is the GH receptor antagonist. It inhibits GH action by binding to and blocking the GH receptor \[[@b24-kjfm-19-0087]\]. Pegvisomant has positive effects on both longevity and healthy aging by increasing insulin sensitivity and lowering the IGF-1 level. Regarding adverse effects, Trainer et al. \[[@b24-kjfm-19-0087]\] reported that liver enzymes were elevated in a few patients.

3. Inhibitors of Mammalian Target of Rapamycin
----------------------------------------------

The mTOR pathway is another nutrient sensing pathway which induces the lifespan extension effect of calorie restriction. The mTOR is a serine/threonine protein kinase that is part of the phosphoinositide 3-kinase--related kinase family and is found in two protein complexes including mTORC1 and mTORC2 with distinct protein components and substrates \[[@b25-kjfm-19-0087]\]. The mTORC1 controls protein translation, autophagy, and various cellular processes through the phosphorylation of substrates such as S6 kinase, 4E binding protein 1, and uncoordinated 51-like kinase 1. In the presence of sufficient nutrients, mTOR turns off stress resistance and autophagy, and subsequently activates translation \[[@b26-kjfm-19-0087]\]. Reduced mTOR signaling through genetic or pharmacological interventions generated lifespan extension in various species and studies are currently being conducted in primates and humans \[[@b27-kjfm-19-0087]\].

Rapamycin is a macrolide and is used as a potent immunosuppressant drug. It is the main antagonist of mTOR signaling. National Institute on Aging Interventions Testing Programs first reported in 2009 that rapamycin extends the lifespan of wild-type mice. Since then, numerous studies have confirmed the strong positive effect of rapamycin on life span \[[@b28-kjfm-19-0087]\]. However, rapamycin has significant adverse effects, including metabolic dysregulation (e.g., hyperglycemia, hyperinsulinemia, and insulin resistance) and proliferative defects in hematopoietic lineages \[[@b29-kjfm-19-0087]\]. These severe side effects limit its consideration and clinical use as an anti-aging drug. Safety studies using rapamycin in healthy individuals are required in the future.

4. Activators of the Sirtuin Pathway
------------------------------------

NAD+ dependent deacetylases known as sirtuins (SIRT 1 to 7) modulate the activity of proteins that are related to energy metabolism, stress resistance, cell survival, and longevity \[[@b30-kjfm-19-0087]\]. Sirtuins are homologous to yeast silent information regulators (sir2). Overexpression of sir2 extended the lifespan of yeast, drosophila, and *Caenorhabditis elegans* \[[@b31-kjfm-19-0087]\]. Although the mechanism by which sirtuins induce anti-aging effects has not been fully elucidated, some studies have shown that sirtuins promote lifespan by stimulating autophagy. Furthermore, there are reports of sirtuins mediating antioxidant defense, improving mitochondrial function, and lowering the serum IGF-1 level \[[@b32-kjfm-19-0087]\]. Thus, sirtuin activating compounds have become a target for many anti-aging studies. Naturally occurring phytochemicals including, quercetin, myricetin, piceatannol, and polyphenols (resveratrol) are known as SIRT-1 agonists \[[@b33-kjfm-19-0087]\]. The effect of resveratrol on improving health and lifespan have been reported in yeast, drosophila, and nematodes \[[@b31-kjfm-19-0087],[@b34-kjfm-19-0087]\]. In other animal models, resveratrol has failed to promote lifespan, but many health benefits have been confirmed \[[@b14-kjfm-19-0087]\]. Resveratrol improved motor performance, bone health, and reduced cardiac failure, seizures, Parkinson's disease, and Alzheimer's disease \[[@b35-kjfm-19-0087]-[@b40-kjfm-19-0087]\]. Resveratrol is also reported to improve memory performance in the elderly and regulate glucose and lipid levels in adults with T2DM and obesity \[[@b41-kjfm-19-0087],[@b42-kjfm-19-0087]\].

HORMONAL REPLACEMENT
====================

Hormone levels decrease with age, and this process is related to decreased secretion from the pituitary gland, adrenals, and gonads \[[@b43-kjfm-19-0087]\]. Decreased hormone levels are associated with decreases in bone mineral density (BMD), muscle mass, sexual desire, erectile function, and intellectual activity. In this context, hormone supplements have been widely used to help reverse the effects of aging and improve the quality of life in the elderly.

1. Estrogen and Progestins
--------------------------

Two-thirds of women suffer from uncomfortable symptoms like hot flashes or vaginal dryness during perimenopause, and HRT is used to reduce such symptoms. Estrogens alone, or together with progester one, have positive effects on osteoporosis treatment and have been used to prevent vertebral and non-vertebral fractures. However, a Women's Health Initiative (WHI) study reported a higher risk for cardiovascular disease, thromboembolic event, stroke, and breast cancer with a combined treatment of estrogens and progestin \[[@b44-kjfm-19-0087]\]. Following the results of the WHI study, new guidelines recommended hormone supplements with lower dose for the shortest amount of time. The Food and Drug Administration in the United States suggests using HRT only for hot flashes and vaginal dryness \[[@b45-kjfm-19-0087]\]. HRT can also be used for the prevention of osteoporosis when other treatments are not available \[[@b45-kjfm-19-0087]\].

2. Testosterone
---------------

Low testosterone levels in older men has been associated with various age-associated conditions \[[@b46-kjfm-19-0087],[@b47-kjfm-19-0087]\]. Sarcopenia and osteoporosis are more frequent in older men with low plasma testosterone levels \[[@b48-kjfm-19-0087],[@b49-kjfm-19-0087]\]. Furthermore, several studies have demonstrated a relationship between low testosterone levels and mild cognitive impairment and Alzheimer's disease \[[@b50-kjfm-19-0087]\]. Thus, testosterone replacement therapy is beneficial as it can increase muscle mass, strength, and BMD in elderly men \[[@b51-kjfm-19-0087]\]. Cognitive function, including verbal, spatial, working memory, and visuospatial function, was improved by testosterone supplementation in elderly men \[[@b45-kjfm-19-0087]\]. One of the adverse effects of testosterone administration is polycythemia. For this reason, patients undergoing testosterone replacement therapy should have their hemoglobin or hematocrit levels checked every 6 months for a total duration of 18 months. Another main concern with testosterone replacement therapy is the potential risk of aggravating prostate cancer. Animal studies have reported that prostate cancer growth was stimulated by testosterone administration \[[@b52-kjfm-19-0087]\]. Thus, although recent studies have failed to confirm a relationship between testosterone levels and the risk of prostate cancer, testosterone replacement therapy should be seriously reconsidered in patients with active prostate cancer \[[@b53-kjfm-19-0087],[@b54-kjfm-19-0087]\]. In general, the absolute contraindications of testosterone replacement therapy are as follows: suspected prostate cancer, severe symptoms of the lower urinary tract such as an International Prostate Symptom Score \>19, hematocrit \>50%, ischemic heart disease in the preceding 6 months, poorly controlled congestive heart failure, and untreated sleep apnea \[[@b45-kjfm-19-0087]\].

3. Dehydroepiandrosterone
-------------------------

The dehydroepiandrosterone (DHEA) and its metabolite DHEA-sulfate are precursors for sex hormones produced by the adrenal gland, which are subsequently transformed into androgen or estrogen in the target tissue \[[@b45-kjfm-19-0087]\]. The decline of plasma DHEA levels with age is clinically associated with various age-related conditions \[[@b55-kjfm-19-0087]\]. Since ovarian production of estrogen decreases in postmenopausal women, the adrenal gland is the only source of estrogen through the peripheral conversion of DHEA \[[@b56-kjfm-19-0087]\]. In previous studies, DHEA supplementation was positively associated with muscle mass, muscle strength, physical performance, and BMD in both men and women \[[@b57-kjfm-19-0087]-[@b60-kjfm-19-0087]\]. Furthermore, DHEA administration has demonstrated beneficial effects on mood and sexual function \[[@b61-kjfm-19-0087],[@b62-kjfm-19-0087]\]. However, the relationship between DHEA and cognitive function has not been sufficiently researched \[[@b45-kjfm-19-0087]\]. Recent studies reported that low DHEA levels are related to a higher risk for atherosclerosis, heart failure, cardiovascular complications, and overall mortality \[[@b63-kjfm-19-0087]\]. Nevertheless, the relationship between DHEA and cardiovascular disease risk factors is still controversial. The adverse effects of DHEA are minimal, such as mild acne, seborrhea, facial hair growth, and ankle swelling in women \[[@b64-kjfm-19-0087],[@b65-kjfm-19-0087]\]. There was no significant effect on hormone-dependent tumors such as breast and prostate cancer \[[@b56-kjfm-19-0087],[@b66-kjfm-19-0087]\], but longer and larger studies are warranted to sufficiently prove the safety of DHEA. DHEA is not allowed in the Republic of Korea even though it is one of the most widely used anti-aging hormones in the United States.

GUT MICROBIOTA
==============

1. Gut Microbiota
-----------------

In recent years, the significant role of microbiota in regulating health status and lifespan has been demonstrated \[[@b2-kjfm-19-0087]\]. Microorganisms have been shown to affect many essential physiological and metabolic functions of host organisms and contribute to the maturation of immune function during early development \[[@b67-kjfm-19-0087]\]. Healthy gut microbiota plays a vital role in resistance to infection, inflammation, autoimmune and cancer prevention, and the regulation of the brain-gut axis \[[@b68-kjfm-19-0087]\]. Recently, many studies have reported evidence that microbiome-targeted interventions can have a therapeutic potential not only for age-associated diseases, but also for slowing down the aging process and for promoting longevity. In the gut of individuals living for over 100 years (centenarians), the *Firmicutes* population was rearranged and *Proteobacteria* was enriched \[[@b69-kjfm-19-0087]\]. The remodeling of the centenarians' microbiota is also characterized by a substantial decrease in *Faecalibacterium prausnitzii* and its relatives, which are symbiotics species with pronounced anti-inflammatory activity. *Eubacterium limosum* and its relatives, which are signature bacteria of a long life span, were higher in centenarians \[[@b69-kjfm-19-0087]\]. Another centenarian study reported that genes involved in short-chain fatty acid synthesis and the saccharolytic potential are decreased, while proteolytic functions of the intestinal metagenome were increased in elderly people compared to younger adults \[[@b70-kjfm-19-0087]\]. However, microbiota composition can be profoundly influenced by several confounding factors including diet, prebiotics, level of physical activity, drug use, and exposure to psychological stressors. Therefore, any interpretation of the results should take these confounding variables into account.

2. Fecal Microbiota Transplantation
-----------------------------------

Microbiota-targeted interventions include prebiotics and probiotics, particularly those containing *Bifidobacterium* and *Lactobacillus* \[[@b71-kjfm-19-0087],[@b72-kjfm-19-0087]\]. The probiotic *Lactobacillus rhamnosus* GG ATCC 53103 has been shown to promote the anti-inflammatory pathways of resident microorganisms \[[@b73-kjfm-19-0087]\]. Fecal microbiota transplantation (FMT) is a radical management program that is used to restore the intestinal ecosystem through the transferring of liquid filtrate feces from a healthy donor into the recipient's gastrointestinal tract \[[@b74-kjfm-19-0087]\]. FMT has been used as a therapeutic option for *Clostridium difficile* infection \[[@b75-kjfm-19-0087]\]. More recently, however, its potential benefit and safety have been demonstrated in non-gastrointestinal diseases, including those commonly associated with aging, T2DM, metabolic syndrome, atherosclerosis, and neurodegenerative diseases \[[@b68-kjfm-19-0087],[@b76-kjfm-19-0087]\]. Despite the great therapeutic potential of the FMT procedure, its implementation in clinical practice is limited by several concerns. These concerns include problems with donor screening, the limited viability of fresh stool samples, fears about potential pathogen transmission, lack of a standardized treatment regimen, and patients not consenting to be treated \[[@b76-kjfm-19-0087]\].

VITAMIN D
=========

Vitamin D is a significant pro-hormone for optimal intestinal calcium absorption for the mineralization of bone \[[@b77-kjfm-19-0087]\]. Recently, many studies have revealed numerous positive effects of vitamin D use in the elderly population. Vitamin D deficiency in the elderly is associated with decreased cognitive function, a higher risk of Alzheimer's disease \[[@b78-kjfm-19-0087]\], loss of muscle mass and function \[[@b79-kjfm-19-0087]\], and osteoporosis. Cross-sectional studies have demonstrated that a low level of vitamin D is related to a higher risk of cardiovascular diseases such as hypertension, heart failure, and ischemic heart disease \[[@b80-kjfm-19-0087],[@b81-kjfm-19-0087]\]. However, the effects of vitamin D as a supplement are still controversial. One study demonstrated that a high serum vitamin D concentration is associated with high atherosclerosis cardiovascular disease risk scores \[[@b82-kjfm-19-0087]\].

Since vitamin D production is usually stimulated by adequate sun exposure, vitamin D levels tend to be lower in elderly people with reduced outside activity. Vitamin D therapy in the elderly was shown to improve muscle mass and performance, and to a reduced the rate of falls \[[@b79-kjfm-19-0087]\]. Furthermore, a recent study reported that vitamin D also has an anti-cancer effect by inhibiting cancer cell growth in several types of cancer \[[@b83-kjfm-19-0087]\]. In this regard, numerous agencies and scientific organizations have developed recommendations for vitamin D therapy and also provide guidance on optimal serum 25-hydroxyvitamin D (25\[OH\]D) concentrations. The general target for the 25(OH)D concentration is above 30 ng/mL, and the replacement dose can vary, ranging from between 400 and 2,000 IU/d depending on age, body weight, disease status, and ethnicity \[[@b84-kjfm-19-0087]\]. Vitamin D intake through natural food sources such as milk, beverages made from soy, almonds, and coconuts is also important in elderly people with low vitamin D levels \[[@b84-kjfm-19-0087]\].

CONCLUSION
==========

Anti-aging medicine is a growing field in locations with an aging population, particularly in developed countries. Available anti-aging interventions are categorized in [Table 1](#t1-kjfm-19-0087){ref-type="table"} according to their mechanisms of action. CRM define compounds that imitate the outcome of calorie restriction, and these include the activator of AMPK (metformin), inhibitor of GH/IGF-1 axis (pegvisomant), inhibitor of mTOR (rapamycin), and activator of the sirtuin pathway (resveratrol). Hormonal replacement such as estrogen, progestin, testosterone, and DHEA in the elderly have been widely used to improve various symptoms associated with frailty, body composition, cardiometabolic diseases, neurodegenerative diseases, and quality of life. Since HRT can increase the risk of thromboembolism or some types of cancer, it should be used with precautions. The composition of healthy gut microbiota through prebiotic/probiotics and FMT has a great potential for anti-aging medicine. Furthermore, vitamin D is expected to be a main anti-aging medicine in the near future due to its numerous positive effects in elderly population.
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![Schematic view of the interrelationship between calorie restriction mimetics and oxidative stress and their clinical implications on longevity. GH, growth hormone; IGF-1, insulin-like growth factor-1; PI3K, phosphoinositide 3-kinase; mTOR, mammalian target of rapamycin; TSC, tuberous sclerosis complex; S6K, S6 kinase; eIF4E, eukaryotic initiation factor 4E; 4E-BP1, 4E binding protein 1; ROS, reactive oxygen species.](kjfm-19-0087f1){#f1-kjfm-19-0087}

###### 

Types of anti-aging intervention

  Category according to mechanism                                   Drug or supplement
  ----------------------------------------------------------------- ------------------------------------------------------------------
  Calorie restriction mimetics                                      
   Activation of AMP protein kinase                                 Metformin
   Inhibition of growth hormone/insulin like growth factor-1 axis   Pegvisomant
   Inhibition of mammalian target of rapamycin                      Rapamycin
   Activation of the sirtuin pathway                                Resveratrol
  Hormonal replacement                                              Estrogen and progestin, testosterone, and dehydroepiandrosterone
  Gut microbiota                                                    Probiotics, prebiotics, fecal microbiota transplantation
  Vitamin D                                                         Vitamin D 400 to 2,000 IU/d with sunlight exposure and foods
